Compare Wegovy Vs Mounjaro: Mechanisms, Dosing & UK Availability
Wegovy V Mounjaro Stock Availability: Real-Time UK Supply
Finding reliable stock for weight management injections has become increasingly challenging across UK pharmacies. EverydayMeds maintains consistent availability for both Wegovy and Mounjaro through established supply partnerships with Novo Nordisk and Eli Lilly respectively. Our inventory management system ensures all Wegovy doses from starter 0.25mg through to maintenance 2.4mg remain accessible without waitlists. Unlike many providers who face intermittent shortages, we've invested in cold storage infrastructure and demand forecasting to prevent stock-outs that could disrupt your treatment journey.
Both treatments arrive via temperature-controlled delivery within 24 hours of prescription approval, eliminating the anxiety of wondering when your next dose will become available. This reliability proves particularly valuable during the dose escalation phase when timing consistency affects tolerability and efficacy. Whether you're comparing Wegovy v Mounjaro for initial treatment or switching between options, our Stock Available levels ensure seamless continuation of your weight management programme.
Wegovy V Mounjaro Pricing: Transparent UK Costs & Bundle Options
Wegovy pricing starts at £79.99 for the 0.25mg starter dose, progressing to £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), and £209.99 for the maintenance 2.4mg strength. New customers apply code FIRST40 at checkout to reach these final prices, while returning patients use DOSE25. Our bundle options provide convenient multi-dose packages, such as the Intro Duo (0.25mg & 0.5mg) for £169.99, covering your first eight weeks of treatment. The Ultimate Stability Trio offers three months of maintenance 2.4mg supply for £649.99, ensuring uninterrupted access during the crucial maintenance phase.
When weighing Wegovy v Mounjaro costs, both treatments fall within similar price ranges as prescription-only medicines requiring specialist prescriber oversight. Payment plans aren't typically available through the NHS for either option, making private prescription costs an important consideration. EverydayMeds pricing includes the prescriber consultation, clinical review, and cold-chain delivery, providing transparent all-inclusive costs without hidden fees that some providers add during checkout.
Clinical Evidence: Wegovy V Mounjaro Trial Data Comparison
Wegovy demonstrated significant efficacy in the STEP clinical trial programme, with participants achieving approximately 15% average weight loss at 68 weeks when combined with diet and exercise (Wilding et al., NEJM, 2021). The STEP 1 trial showed 83.5% of participants lost at least 5% of their baseline weight, while 66.1% achieved 10% or greater reduction. These outcomes occurred alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management approach.
Mounjaro's SURMOUNT trials evaluated tirzepatide specifically for weight management, though direct comparison between Wegovy v Mounjaro trial results requires caution due to different study populations, endpoints, and methodologies. Both treatments underwent rigorous Phase 3 testing with thousands of participants over extended periods. Your prescriber can discuss which evidence base aligns better with your medical profile and weight management goals during the clinical assessment process.
How Wegovy Works: GLP-1 Mechanism For Weight Management
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your intestines produce after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, helping you feel fuller after smaller meal portions. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness between meals. Unlike stimulant-based appetite suppressants, Wegovy works through natural metabolic pathways your body already uses for appetite regulation. Clinical studies suggest it may also reduce food cravings and the reward response to high-calorie foods, though individual responses vary considerably. This mechanism requires consistent weekly dosing to maintain therapeutic levels and optimal appetite control effects.
Ordering Process: From Assessment To Next-Day Delivery
EverydayMeds streamlines access to both Wegovy and Mounjaro through a comprehensive yet efficient online process designed around clinical safety standards. The initial assessment takes approximately three minutes, covering medical history, current medications, previous weight loss attempts, and contraindication screening through our secure platform. Qualified prescribers review each application within three working days (or 24 hours with express service), ensuring thorough evaluation before approving treatment. Once prescribed, your chosen medication ships via next-day delivery using temperature-controlled packaging that maintains the required 2-8°C storage throughout transit. Our pharmacy team provides injection training materials and ongoing support, with direct access to clinical advice should questions arise during your treatment journey.
Storage & Practical Considerations: Wegovy V Mounjaro Differences
Both treatments require refrigeration at 2-8°C before first use, but Wegovy offers superior travel flexibility with six weeks of room temperature stability compared to Mounjaro's 21-day limit. This advantage proves valuable for extended holidays, business travel, or situations where refrigeration access becomes temporarily unavailable. Wegovy uses Novo Nordisk's FlexTouch pen system, which many patients find intuitive after brief training, while Mounjaro utilises Eli Lilly's KwikPen technology. Both systems provide pre-measured doses with hidden needles to reduce injection anxiety. The weekly injection schedule remains consistent between options, though dose escalation timelines differ slightly, with Wegovy following a standardised 16-week escalation to maintenance dosing. Your prescriber will provide detailed storage and administration guidance specific to your chosen treatment option.
Wegovy V Mounjaro: Mechanism Differences For Treatment Selection
The fundamental distinction between these treatments lies in their receptor targeting approaches, influencing how each affects appetite regulation and metabolic function. Wegovy exclusively targets GLP-1 receptors, providing proven efficacy through a well-established mechanism that's been studied extensively in both diabetes and weight management contexts. Mounjaro acts as a dual agonist, targeting both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously, offering a novel approach to weight and metabolic regulation.
Neither mechanism is inherently superior - the choice between Wegovy v Mounjaro often depends on individual response patterns, medical history, and specific health considerations your prescriber will evaluate. Some patients respond better to single-target GLP-1 activation, while others may benefit from the dual-pathway approach, though predicting individual response remains challenging. Both treatments require identical lifestyle modifications including reduced-calorie diet and increased physical activity to achieve optimal outcomes within their licensed indications.
Complete Wegovy V Mounjaro Service: Expert Clinical Support
EverydayMeds provides comprehensive support throughout your weight management journey, whether you choose Wegovy, Mounjaro, or need to switch between treatments based on clinical response. Our prescribers, working under GPhC registration #9012878, offer ongoing medication reviews, side effect management, and dose adjustment guidance as your treatment progresses. Both Wegovy and Mounjaro are prescription-only medicines requiring specialist oversight, particularly during the initial months when dose escalation and side effect monitoring prove most critical. We maintain detailed treatment records, enabling seamless communication with your GP and ensuring continuity of care across all healthcare providers. New customers use code FIRST40 at checkout, while returning patients apply DOSE25 to access our competitive pricing structure, with both treatments available for immediate dispatch via our secure online platform at https://everydaymeds.co.uk/collections/wegovy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
